论文信息 - Reversible language regression as an adverse effect of topiramate treatment in children

Reversible language regression as an adverse effect of topiramate treatment in children

Profound language regression developed in three children with epilepsy 4 to 28 weeks after beginning topiramate (TPM). TPM was administered as an adjunctive antiepileptic drug at doses of 2.5 to 6.0 mg/kg/day. Language functions recovered while TPM was being reduced in dose or stopped.

R. Shalev | V. Gross‐Tsur

[1] Jennie Z Ma,et al. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial , 2003, The Lancet.

[2] Josemir W Sander,et al. Topiramate and word-finding difficulties in patients with epilepsy , 2003, Neurology.

[3] R. Mattson,et al. Topiramate, carbamazepine and valproate monotherapy: double‐blind comparison in newly diagnosed epilepsy , 2003, Acta neurologica Scandinavica.

[4] F. Dubeau,et al. The Effects of Adjunctive Topiramate on Cognitive Function in Patients with Epilepsy , 2003, Epilepsia.

[5] G. Pledger,et al. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy , 2003, Neurology.

[6] F. Volkmar,et al. Language regression in childhood. , 2001, Pediatric neurology.

[7] E. Silliman,et al. An Open-Label Trial of Bromocriptine in Nonfluent Aphasia: A Qualitative Analysis of Word Storage and Retrieval , 2000, Brain and Language.

[8] Josemir W Sander,et al. Prognostic Factors Affecting Long‐Term Retention of Topiramate in Patients with Chronic Epilepsy , 2000, Epilepsia.

[9] G. Pledger,et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children , 1999, Neurology.

[10] R. Davis,et al. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. , 1997, Drugs.